| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| DHF92406A |
Research Grade Elranatamab |
100 ug |
$615.00
|
 |
BUY
|
| DHF92406B |
Research Grade Elranatamab |
1.0 mg |
$2,235.00
|
 |
BUY
|
| DHE58702B |
Research Grade GLP1-like peptide conjugated to Anti-Human GIPR (AMG 133) mAb |
|
$2,210.00
|
 |
BUY
|
| DHE58702A |
Research Grade GLP1-like peptide conjugated to Anti-Human GIPR (AMG 133) mAb |
|
$615.00
|
 |
BUY
|
| DHC85104A |
Research Grade Ivicentamab |
100 ug |
$420.00
|
 |
BUY
|
| DHC85104B |
Research Grade Ivicentamab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHJ92702A |
Research Grade Ligelizumab |
100 ug |
$420.00
|
 |
BUY
|
| DHJ92702B |
Research Grade Ligelizumab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHE57001A |
Research Grade Mibavademab |
100 ug |
$420.00
|
 |
BUY
|
| DHE57001B |
Research Grade Mibavademab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHJ63105B |
Research Grade Mirikizumab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHJ63105A |
Research Grade Mirikizumab |
100 ug |
$420.00
|
 |
BUY
|
| DVV02802B |
Research Grade Nirsevimab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DVV02802A |
Research Grade Nirsevimab |
100 ug |
$420.00
|
 |
BUY
|
| DVV02801A |
Research Grade Palivizumab |
100 ug |
$420.00
|
 |
BUY
|
| DVV02801B |
Research Grade Palivizumab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHG01304B |
Research Grade Rosopatamab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHG01304A |
Research Grade Rosopatamab |
100 ug |
$420.00
|
 |
BUY
|
| DHK86201A |
Research Grade Seniprutug |
100 ug |
$475.00
|
 |
BUY
|
| DHK86201B |
Research Grade Seniprutug |
1.0 mg |
$1,715.00
|
 |
BUY
|
| DHD68911B |
Research Grade Sotigalimab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHD68911A |
Research Grade Sotigalimab |
100 ug |
$420.00
|
 |
BUY
|
| DHD10834A |
Research Grade Surovatamig |
100µg |
$550.00
|
 |
BUY
|
| DHD10834B |
Research Grade Surovatamig |
1.0 mg |
$2,015.00
|
 |
BUY
|
| DHC34203A |
Research Grade Telisotuzumab |
100 ug |
$420.00
|
 |
BUY
|
| DHC34203B |
Research Grade Telisotuzumab |
1.0 mg |
$1,520.00
|
 |
BUY
|
| DHC34299A |
Research Grade Telisotuzumab vedotin (ADC) |
1.0 mg |
$2,915.00
|
 |
BUY
|
| DHC34299B |
Research Grade Telisotuzumab vedotin (ADC) |
5.0 mg |
$6,325.00
|
 |
BUY
|
| DHC09698B |
Research Grade Trastuzumab deruxtecan (ADC) |
5.0 mg |
$7,240.00
|
 |
BUY
|
| DHC09698A |
Research Grade Trastuzumab deruxtecan (ADC) |
1.0 mg |
$2,915.00
|
 |
BUY
|
| DHB54001A |
Research Grade Tulisokibart |
100 ug |
$475.00
|
 |
BUY
|
| DHB54001B |
Research Grade Tulisokibart |
1.0 mg |
$1,715.00
|
 |
BUY
|
| DHJ27904A |
Research Grade Ucenprubart |
100 µg |
$475.00
|
 |
BUY
|
| DHJ27904B |
Research Grade Ucenprubart |
1.0 mg |
$1,715.00
|
 |
BUY
|
| DHK27201A |
Research Grade Verekitug |
100µg |
$475.00
|
 |
BUY
|
| DHK27201B |
Research Grade Verekitug |
1mg |
$1,705.00
|
 |
BUY
|